+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market 2023-2027

  • PDF Icon

    Report

  • 170 Pages
  • September 2023
  • Region: Global
  • TechNavio
  • ID: 5576351
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The respiratory drugs market is forecasted to grow by USD 30.23 bn during 2022-2027, accelerating at a CAGR of 6.38% during the forecast period. The report on the respiratory drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by need for sustainable and safe respiratory drugs, rising prevalence of respiratory diseases, and increasing tobacco consumption.

The respiratory drugs market is segmented as below:

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

By Type

  • Asthma
  • COPD
  • Allergic rhinitis
  • Cystic fibrosis
  • Other respiratory diseases

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the emergence of telehealth and remote monitoring as one of the prime reasons driving the respiratory drugs market growth during the next few years. Also, adoption of biologics and targeted therapies and rising digital health integration will lead to sizable demand in the market.

The report on the respiratory drugs market covers the following areas:

  • Respiratory drugs market sizing
  • Respiratory drugs market forecast
  • Respiratory drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading respiratory drugs market vendors that include Abbott Laboratories, AbbVie Inc., Aerogen Pharma Ltd., AstraZeneca Plc, Aurobindo Pharma Ltd., Boehringer Ingelheim International GmbH, Celon Pharma SA, Cipla Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Laboratory Corp. of America Holdings, Lupin Ltd., Medisol Lifescience Pvt. Ltd., Merck and Co. Inc., Novartis AG, Sumitomo Pharma Co. Ltd., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Inc., Wellona Pharma, and Glenmark Pharmaceuticals Ltd.. Also, the respiratory drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global respiratory drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global respiratory drugs market 2017 - 2021 ($ billion)
4.2 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Hospital pharmacies - Market size and forecast 2022-2027
Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
6.4 Retail pharmacies - Market size and forecast 2022-2027
Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
6.5 Online pharmacies - Market size and forecast 2022-2027
Exhibit 42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Distribution Channel
Exhibit 46: Market opportunity by Distribution Channel ($ billion)
Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)
7 Market Segmentation by Type
7.1 Market segments
Exhibit 48: Chart on Type - Market share 2022-2027 (%)
Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 50: Chart on Comparison by Type
Exhibit 51: Data Table on Comparison by Type
7.3 Asthma - Market size and forecast 2022-2027
Exhibit 52: Chart on Asthma - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Data Table on Asthma - Market size and forecast 2022-2027 ($ billion)
Exhibit 54: Chart on Asthma - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Asthma - Year-over-year growth 2022-2027 (%)
7.4 COPD - Market size and forecast 2022-2027
Exhibit 56: Chart on COPD - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Data Table on COPD - Market size and forecast 2022-2027 ($ billion)
Exhibit 58: Chart on COPD - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on COPD - Year-over-year growth 2022-2027 (%)
7.5 Allergic rhinitis - Market size and forecast 2022-2027
Exhibit 60: Chart on Allergic rhinitis - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Data Table on Allergic rhinitis - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Chart on Allergic rhinitis - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Allergic rhinitis - Year-over-year growth 2022-2027 (%)
7.6 Cystic fibrosis - Market size and forecast 2022-2027
Exhibit 64: Chart on Cystic fibrosis - Market size and forecast 2022-2027 ($ billion)
Exhibit 65: Data Table on Cystic fibrosis - Market size and forecast 2022-2027 ($ billion)
Exhibit 66: Chart on Cystic fibrosis - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Cystic fibrosis - Year-over-year growth 2022-2027 (%)
7.7 Other respiratory diseases - Market size and forecast 2022-2027
Exhibit 68: Chart on Other respiratory diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 69: Data Table on Other respiratory diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 70: Chart on Other respiratory diseases - Year-over-year growth 2022-2027 (%)
Exhibit 71: Data Table on Other respiratory diseases - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Type
Exhibit 72: Market opportunity by Type ($ billion)
Exhibit 73: Data Table on Market opportunity by Type ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 Canada - Market size and forecast 2022-2027
Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 111: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 112: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 113: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 114: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 117: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 119: Overview on factors of disruption
11.4 Industry risks
Exhibit 120: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 121: Vendors covered
12.2 Market positioning of vendors
Exhibit 122: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 123: Abbott Laboratories - Overview
Exhibit 124: Abbott Laboratories - Business segments
Exhibit 125: Abbott Laboratories - Key news
Exhibit 126: Abbott Laboratories - Key offerings
Exhibit 127: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 128: AbbVie Inc. - Overview
Exhibit 129: AbbVie Inc. - Product/Service
Exhibit 130: AbbVie Inc. - Key news
Exhibit 131: AbbVie Inc. - Key offerings
12.5 Aerogen Pharma Ltd.
Exhibit 132: Aerogen Pharma Ltd. - Overview
Exhibit 133: Aerogen Pharma Ltd. - Product/Service
Exhibit 134: Aerogen Pharma Ltd. - Key offerings
12.6 AstraZeneca Plc
Exhibit 135: AstraZeneca Plc - Overview
Exhibit 136: AstraZeneca Plc - Product/Service
Exhibit 137: AstraZeneca Plc - Key news
Exhibit 138: AstraZeneca Plc - Key offerings
12.7 Boehringer Ingelheim International GmbH
Exhibit 139: Boehringer Ingelheim International GmbH - Overview
Exhibit 140: Boehringer Ingelheim International GmbH - Business segments
Exhibit 141: Boehringer Ingelheim International GmbH - Key news
Exhibit 142: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 143: Boehringer Ingelheim International GmbH - Segment focus
12.8 Celon Pharma SA
Exhibit 144: Celon Pharma SA - Overview
Exhibit 145: Celon Pharma SA - Business segments
Exhibit 146: Celon Pharma SA - Key offerings
Exhibit 147: Celon Pharma SA - Segment focus
12.9 Cipla Ltd.
Exhibit 148: Cipla Ltd. - Overview
Exhibit 149: Cipla Ltd. - Business segments
Exhibit 150: Cipla Ltd. - Key news
Exhibit 151: Cipla Ltd. - Key offerings
Exhibit 152: Cipla Ltd. - Segment focus
12.10 F. Hoffmann La Roche Ltd.
Exhibit 153: F. Hoffmann La Roche Ltd. - Overview
Exhibit 154: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 155: F. Hoffmann La Roche Ltd. - Key news
Exhibit 156: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 157: F. Hoffmann La Roche Ltd. - Segment focus
12.11 GlaxoSmithKline Plc
Exhibit 158: GlaxoSmithKline Plc - Overview
Exhibit 159: GlaxoSmithKline Plc - Business segments
Exhibit 160: GlaxoSmithKline Plc - Key news
Exhibit 161: GlaxoSmithKline Plc - Key offerings
Exhibit 162: GlaxoSmithKline Plc - Segment focus
12.12 Glenmark Pharmaceuticals Ltd.
Exhibit 163: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 164: Glenmark Pharmaceuticals Ltd. - Product/Service
Exhibit 165: Glenmark Pharmaceuticals Ltd. - Key offerings
12.13 Lupin Ltd.
Exhibit 166: Lupin Ltd. - Overview
Exhibit 167: Lupin Ltd. - Product/Service
Exhibit 168: Lupin Ltd. - Key news
Exhibit 169: Lupin Ltd. - Key offerings
12.14 Novartis AG
Exhibit 170: Novartis AG - Overview
Exhibit 171: Novartis AG - Business segments
Exhibit 172: Novartis AG - Key offerings
Exhibit 173: Novartis AG - Segment focus
12.15 Sumitomo Pharma Co. Ltd.
Exhibit 174: Sumitomo Pharma Co. Ltd. - Overview
Exhibit 175: Sumitomo Pharma Co. Ltd. - Business segments
Exhibit 176: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibit 177: Sumitomo Pharma Co. Ltd. - Segment focus
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 178: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 179: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 180: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 181: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 182: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Vertex Pharmaceuticals Inc.
Exhibit 183: Vertex Pharmaceuticals Inc. - Overview
Exhibit 184: Vertex Pharmaceuticals Inc. - Product/Service
Exhibit 185: Vertex Pharmaceuticals Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 186: Inclusions checklist
Exhibit 187: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 188: Currency conversion rates for US$
13.4 Research methodology
Exhibit 189: Research methodology
Exhibit 190: Validation techniques employed for market sizing
Exhibit 191: Information sources
13.5 List of abbreviations
Exhibit 192: List of abbreviations
Exhibits:
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global respiratory drugs market 2017 - 2021 ($ billion)
Exhibits 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
Exhibits 20: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Distribution Channel
Exhibits 33: Data Table on Comparison by Distribution Channel
Exhibits 34: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits 35: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits 36: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits 39: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits 40: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits 43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits 44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 46: Market opportunity by Distribution Channel ($ billion)
Exhibits 47: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits 48: Chart on Type - Market share 2022-2027 (%)
Exhibits 49: Data Table on Type - Market share 2022-2027 (%)
Exhibits 50: Chart on Comparison by Type
Exhibits 51: Data Table on Comparison by Type
Exhibits 52: Chart on Asthma - Market size and forecast 2022-2027 ($ billion)
Exhibits 53: Data Table on Asthma - Market size and forecast 2022-2027 ($ billion)
Exhibits 54: Chart on Asthma - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Asthma - Year-over-year growth 2022-2027 (%)
Exhibits 56: Chart on COPD - Market size and forecast 2022-2027 ($ billion)
Exhibits 57: Data Table on COPD - Market size and forecast 2022-2027 ($ billion)
Exhibits 58: Chart on COPD - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on COPD - Year-over-year growth 2022-2027 (%)
Exhibits 60: Chart on Allergic rhinitis - Market size and forecast 2022-2027 ($ billion)
Exhibits 61: Data Table on Allergic rhinitis - Market size and forecast 2022-2027 ($ billion)
Exhibits 62: Chart on Allergic rhinitis - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Allergic rhinitis - Year-over-year growth 2022-2027 (%)
Exhibits 64: Chart on Cystic fibrosis - Market size and forecast 2022-2027 ($ billion)
Exhibits 65: Data Table on Cystic fibrosis - Market size and forecast 2022-2027 ($ billion)
Exhibits 66: Chart on Cystic fibrosis - Year-over-year growth 2022-2027 (%)
Exhibits 67: Data Table on Cystic fibrosis - Year-over-year growth 2022-2027 (%)
Exhibits 68: Chart on Other respiratory diseases - Market size and forecast 2022-2027 ($ billion)
Exhibits 69: Data Table on Other respiratory diseases - Market size and forecast 2022-2027 ($ billion)
Exhibits 70: Chart on Other respiratory diseases - Year-over-year growth 2022-2027 (%)
Exhibits 71: Data Table on Other respiratory diseases - Year-over-year growth 2022-2027 (%)
Exhibits 72: Market opportunity by Type ($ billion)
Exhibits 73: Data Table on Market opportunity by Type ($ billion)
Exhibits 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 77: Chart on Geographic comparison
Exhibits 78: Data Table on Geographic comparison
Exhibits 79: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 80: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 81: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 84: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 88: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 96: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 97: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits 104: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 107: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 108: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 109: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 110: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 111: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 112: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 113: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 114: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 115: Market opportunity By Geographical Landscape ($ billion)
Exhibits 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 117: Impact of drivers and challenges in 2022 and 2027
Exhibits 118: Overview on Criticality of inputs and Factors of differentiation
Exhibits 119: Overview on factors of disruption
Exhibits 120: Impact of key risks on business
Exhibits 121: Vendors covered
Exhibits 122: Matrix on vendor position and classification
Exhibits 123: Abbott Laboratories - Overview
Exhibits 124: Abbott Laboratories - Business segments
Exhibits 125: Abbott Laboratories - Key news
Exhibits 126: Abbott Laboratories - Key offerings
Exhibits 127: Abbott Laboratories - Segment focus
Exhibits 128: AbbVie Inc. - Overview
Exhibits 129: AbbVie Inc. - Product/Service
Exhibits 130: AbbVie Inc. - Key news
Exhibits 131: AbbVie Inc. - Key offerings
Exhibits 132: Aerogen Pharma Ltd. - Overview
Exhibits 133: Aerogen Pharma Ltd. - Product/Service
Exhibits 134: Aerogen Pharma Ltd. - Key offerings
Exhibits 135: AstraZeneca Plc - Overview
Exhibits 136: AstraZeneca Plc - Product/Service
Exhibits 137: AstraZeneca Plc - Key news
Exhibits 138: AstraZeneca Plc - Key offerings
Exhibits 139: Boehringer Ingelheim International GmbH - Overview
Exhibits 140: Boehringer Ingelheim International GmbH - Business segments
Exhibits 141: Boehringer Ingelheim International GmbH - Key news
Exhibits 142: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 143: Boehringer Ingelheim International GmbH - Segment focus
Exhibits 144: Celon Pharma SA - Overview
Exhibits 145: Celon Pharma SA - Business segments
Exhibits 146: Celon Pharma SA - Key offerings
Exhibits 147: Celon Pharma SA - Segment focus
Exhibits 148: Cipla Ltd. - Overview
Exhibits 149: Cipla Ltd. - Business segments
Exhibits 150: Cipla Ltd. - Key news
Exhibits 151: Cipla Ltd. - Key offerings
Exhibits 152: Cipla Ltd. - Segment focus
Exhibits 153: F. Hoffmann La Roche Ltd. - Overview
Exhibits 154: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 155: F. Hoffmann La Roche Ltd. - Key news
Exhibits 156: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 157: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 158: GlaxoSmithKline Plc - Overview
Exhibits 159: GlaxoSmithKline Plc - Business segments
Exhibits 160: GlaxoSmithKline Plc - Key news
Exhibits 161: GlaxoSmithKline Plc - Key offerings
Exhibits 162: GlaxoSmithKline Plc - Segment focus
Exhibits 163: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits 164: Glenmark Pharmaceuticals Ltd. - Product/Service
Exhibits 165: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits 166: Lupin Ltd. - Overview
Exhibits 167: Lupin Ltd. - Product/Service
Exhibits 168: Lupin Ltd. - Key news
Exhibits 169: Lupin Ltd. - Key offerings
Exhibits 170: Novartis AG - Overview
Exhibits 171: Novartis AG - Business segments
Exhibits 172: Novartis AG - Key offerings
Exhibits 173: Novartis AG - Segment focus
Exhibits 174: Sumitomo Pharma Co. Ltd. - Overview
Exhibits 175: Sumitomo Pharma Co. Ltd. - Business segments
Exhibits 176: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibits 177: Sumitomo Pharma Co. Ltd. - Segment focus
Exhibits 178: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 179: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 180: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 181: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 182: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 183: Vertex Pharmaceuticals Inc. - Overview
Exhibits 184: Vertex Pharmaceuticals Inc. - Product/Service
Exhibits 185: Vertex Pharmaceuticals Inc. - Key offerings
Exhibits 186: Inclusions checklist
Exhibits 187: Exclusions checklist
Exhibits 188: Currency conversion rates for US$
Exhibits 189: Research methodology
Exhibits 190: Validation techniques employed for market sizing
Exhibits 191: Information sources
Exhibits 192: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global respiratory drugs market: Abbott Laboratories, AbbVie Inc., Aerogen Pharma Ltd., AstraZeneca Plc, Aurobindo Pharma Ltd., Boehringer Ingelheim International GmbH, Celon Pharma SA, Cipla Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Laboratory Corp. of America Holdings, Lupin Ltd., Medisol Lifescience Pvt. Ltd., Merck and Co. Inc., Novartis AG, Sumitomo Pharma Co. Ltd., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Inc., Wellona Pharma, and Glenmark Pharmaceuticals Ltd..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is emergence of telehealth and remote monitoring.'
According to the report, one of the major drivers for this market is the need for sustainable and safe respiratory drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AbbVie Inc.
  • Aerogen Pharma Ltd.
  • AstraZeneca Plc
  • Aurobindo Pharma Ltd.
  • Boehringer Ingelheim International GmbH
  • Celon Pharma SA
  • Cipla Ltd.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Laboratory Corp. of America Holdings
  • Lupin Ltd.
  • Medisol Lifescience Pvt. Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • Sumitomo Pharma Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Vertex Pharmaceuticals Inc.
  • Wellona Pharma
  • Glenmark Pharmaceuticals Ltd.

Related Topics

Related Reports

Global Nontuberculous Mycobacterial Infections Market 2024-2028 - Product Image

Global Nontuberculous Mycobacterial Infections Market 2024-2028

  • Report
  • 177 Pages
  • Global
From
Global Upper Respiratory Tract Infection Treatment Market 2024-2028 - Product Image

Global Upper Respiratory Tract Infection Treatment Market 2024-2028

  • Report
  • 170 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Chronic Obstructive Pulmonary Disease Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Levofloxacin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Levofloxacin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 188 Pages
  • Global
From
Respiratory Drug Delivery Market Report 2024-2034 - Product Image

Respiratory Drug Delivery Market Report 2024-2034

  • Report
  • 348 Pages
  • Global
From

About the Respiratory Drugs Market

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.